William E Gannon Jr, MD, was a Chief Medical Officer consultant at PharmaJet, as well as Chief Scientific Officer & Medical Director for Capital City Technical Consulting (CCTC). Previously, he held positions in multinational clinical research organisations, medical device, biotech and pharmaceutical firms, most recently as Vice-President, Clinical & Medical Affairs in the biotechnology arena. Dr Gannon’s experience includes a broad range of therapeutic categories, with a primary focus on therapeutic and diagnostic applications in oncology. He has managed clinical trials and operations as well as the design, corporate and regulatory strategies, regulatory submissions and execution of Phase I-IV clinical trials in the US, Europe and Asia. Dr Gannon is involved in philanthropy in the Washington DC area and currently serves on the board of directors for the Engineering World Health Organization and The Foundation for Sickle Cell Research. He received his medical training and did clinical work at Ross University (Isein, NJ, US), Case Western Reserve (Cleveland, OH, US), and George Washington University (Washington, DC, US), and also has an MBA from George Washington University.